Effect of gemfibrozil on the pharmacokinetics of imatinib in volunteers

Trial Profile

Effect of gemfibrozil on the pharmacokinetics of imatinib in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Sep 2013

At a glance

  • Drugs Imatinib (Primary) ; Gemfibrozil
  • Indications Acute lymphoblastic leukaemia; Chronic myeloid leukaemia; Dermatofibrosarcoma; Dyslipidaemias; Fibroma; Gastrointestinal stromal tumours; Lipid metabolism disorders; Malignant melanoma; Mastocytosis; Myelodysplastic syndromes; Non-small cell lung cancer; Prostate cancer; Sarcoma
  • Focus Pharmacogenomic; Pharmacokinetics
  • Most Recent Events

    • 19 Sep 2013 New trial record
    • 31 Aug 2013 Results presented at the 11th Congress of the European Association for Clinical Pharmacology and Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top